Larvol Delta - Preclinical-characterization-of-LY4402289-a-novel-DLL3targeting-antibody-drug-conjugate-ADC-delivering-a-NAMPT-inhibitor-payload

LY4402289 - Eli Lilly

https://cm.eortc.org/cmPortal/Searchable/ena2026/config/Normal#!abstractdetails/0000997190

Jorge Peiró

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next